INTEGRATED REPORT 2019
Our 2025 strategy
The global healthcare landscape continues to evolve rapidly. Changes in technology, regulations, consumerism, funder behaviours and the economic climate all impact the way we do business. To remain sustainable and future-fit, this year we reviewed our strategy and approved a new Group 2025 strategy.
Our 2025 strategy
A dual focus on offering an integrated healthcare model in southern Africa, and leading diagnostic imaging internationally
Providing a diversified product and service offering, with a growing share of revenue and earnings derived from non-acute sources
Focusing on clinical excellence and building an analytics-led, technologically enabled Group across all markets and businesses
Underpinned by our current strategic pillars
Our people
Data, analytics and information
technology
Clinical quality
Our employees are critical for driving our core business and pursuing growth initiatives across the globe. We will continue to review and improve our people practices to motivate, inspire, retain and attract the best talent in the market.
Ultimately, we want analytics to be a key competitive differentiator. Our ambition is to build a future-fit data and analytics capability, underpinned by enabling technology, to empower our Group to be adaptable, innovative, decisive and insight driven.
Clinical quality is at the core of what we do. We will continue to improve our clinical governance practices across the Group to remain a clinically-led organisation, taking a process-based data-driven approach to continuous quality improvement.
Unpacking our 2025 strategy
While we have different focus areas for southern Africa and our international business, these centre around operational excellence, new growth segments and new market expansion across the short, medium and long term. We will deliver on our strategy over three horizons.
| Horizon | Southern Africa | International |  |
|
| In southern Africa we will expand our focus beyond acute hospitalisation across the healthcare continuum, serving new local markets and ultimately become a global leader in hospital management. | Internationally, we will leverage our expertise to position ourselves as a global leader in diagnostic imaging. | |||
| Focus areas | Focus areas | |||
| Horizon 1 |
Operational excellence |
|
|
|
| Horizon 2 |
New growth segments |
|
|
|
| Horizon 3 |
New market expansion |
|
|
|
As part of our commitment to exploring new growth segments, our focus areas will be on the following:
| Diagnostic imaging in southern Africa |
Outpatient care | Life Molecular Imaging | Government | |||
Alliance Medical is the leading independent provider of medical imaging services in Europe, operating across 10 geographies. In South Africa we have an opportunity to offer high-quality, affordable diagnostic imaging services by integrating diagnostic services into our infrastructure; leveraging Alliance Medical's expertise; and improving scale, standardisation and efficiency. |
In South Africa, the employed uninsured population is not adequately served by traditional primary healthcare models. We want to improve healthcare access and affordability by offering this segment of the population convenient, quality, nurse-led outpatient care, delivered via cutting-edge technology and scaled via partnerships. |
Our strategy is to drive commercial sales of Neuraceq and progress to reimbursement, and to develop pipeline products. |
Across the Group we work with local government to deliver access to high-quality care. We have an explicit intention to continue serving governments in the countries in which we operate, and strengthening these partnerships. |